Xcout Intel
Accent Therapeutics
Accent Therapeutics, Inc. is a biopharmaceutical company headquartered in Lexington, Massachusetts, focused on translating scientific research into novel therapeutics. The company conducts clinical trials, such as Phase 1/2 studies, targeting oncology and other serious diseases.
Subscribe to see Accent Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Accent Therapeutics at a glance
Accent Therapeutics is a biotechnology company headquartered in United States. It has raised at least $75M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Series C, raised $75M in January 2024. Xcout tracks 15 named people at Accent Therapeutics, including Shakti Narayan (Chief Executive Officer).
Accent Therapeutics leadership
- Shakti NarayanChief Executive Officer
- David BrowerChief Business Officer & Head of Finance
- Jason SagerChief Medical Officer
- Serena SilverChief Scientific Officer
- Srinivas ParthasarathyVice President, Business Development & Strategy and Chief of Staff
- Kevin McGannVice President, Finance
9 more named people on record for Accent Therapeutics, with roles, board committees and tenure — see the full roster →
Accent Therapeutics funding rounds
At least $75M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $75M | 14 named | |
| — | Undisclosed | 13 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Accent Therapeutics competitors
A few of Accent Therapeutics's closest competitors — see the full list of competitors and alternatives →
Curis, Inc. is a biotechnology company headquartered in Lexington, Massachusetts. The company is engaged in the research and development of drug candidates for the treatment of human cancers.
Auron Therapeutics, Inc. is a biotechnology company headquartered in Newton, Massachusetts. The company focuses on targeting cell states to deliver next-generation targeted cancer therapies.
Agenus Inc. is a biotechnology company headquartered in Lexington, Massachusetts, focused on the discovery and development of better immunotherapies and cancer treatments.
Triana Biomedicines, Inc. is a private biotechnology company focused on targeted molecular glue discovery. The company is headquartered in Lexington, Massachusetts.
Centessa Pharmaceuticals LLC is a biotechnology research company headquartered in Boston, Massachusetts, United States. The company comprises leaders, innovators, and scientists dedicated to pursuing and developing transformational medicines for patients.
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Get Accent Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Accent Therapeutics in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access